ArticleClinical cardiology2026
The Linear Association Between A Body Shape Index and Abdominal Aortic Calcification in Individuals With Hypertension.
Article in Clinical cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Methodological Issues Related to the Reported Association of A Body Shape Index With Abdominal Aortic Calcification in Patients With Hypertension.Clinical cardiology · 2026Article
- Reconsidering the Clinical Utility of a Body Shape Index for Abdominal Aortic Calcification in Hypertension: From Association to Clinical Applicability.Clinical cardiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectiveThis study aimed to evaluate the association between A Body Shape Index (ABSI) and abdominal aortic calcification (AAC) in individuals with hypertension.
methodsThis cross-sectional analysis utilized data from 1486 participants in the National Health and Nutrition Examination Survey (NHANES). The relationship between ABSI and AAC was evaluated through logistic regression, subgroup analyses, receiver operating characteristic (ROC) curve assessment, and restricted cubic spline (RCS) modeling.
resultsMultivariable logistic regression revealed that each standard deviation increase in ABSI corresponded to a 16.2% elevated AAC risk (OR = 1.162, 95% CI: 1.025-1.318, p = 0.019). Compared with the lowest quartile (Q1), individuals in Q3 and Q4 had significantly higher risks of AAC, with ORs of 1.554 (95% CI: 1.096-2.204, p = 0.013) and 1.503 (95% CI: 1.047-2.157, p = 0.027), respectively. Subgroup analyses revealed a robust association between ABSI and AAC that was consistently observed across strata. ROC curve analysis revealed that ABSI provided moderate discriminative ability for AAC detection in the overall cohort (AUC = 0.625, 95% CI: 0.596-0.654, p < 0.001), males (AUC = 0.632, 95% CI: 0.589-0.675, p < 0.001), and females (AUC = 0.627, 95% CI: 0.588-0.666, p < 0.001). RCS analysis, in both unadjusted and multivariable-adjusted models, RCS analysis confirmed a dose-dependent positive relationship between ABSI and AAC risk (P for nonlinearity > 0.05).
conclusionHigher ABSI levels show a significant, independent association with increased AAC risk in hypertensive patients, suggesting potential clinical value as a indicator for early vascular calcification detection in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.